Our data revealed that the outcome of MSC–tumor interaction is dependent on the nature rather than the type of tumor cells and that epithelial cadherin type 1 (CDH1) and IL-1β expression by tumor cells are key factors in determining the outcome of hMSC–tumor cross-talk. This evidence concerns the gene IL1B and neoplasm.